South & Central America Organoids Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The South and Central America organoids market is projected to grow significantly, reaching approximately US$ 806.23 million by 2031, up from US$ 160.44 million in 2023. This growth represents a compound annual growth rate (CAGR) of 22.4% from 2023 to 2031.

Executive Summary and Market Analysis

The organoids market in South and Central America is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. The market is anticipated to expand due to several factors, including the rising incidence of cancer, increased government initiatives, and enhanced research and development in organoids.

Market Segmentation Analysis

The South and Central America organoids market is categorized based on type, application, source, offering, and method:

Type: The market includes organoids derived from various organs such as the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, the intestine organoids segment held the largest market share.
Application: The applications of organoids are segmented into developmental biology disease, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, personalized medicine, and others. The developmental biology disease segment was the largest in 2023.
Source: The market is divided into organoids sourced from pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells dominating the market share in 2023.
Offering: This segment includes instruments, consumables, and services, with consumables holding the largest share in 2023. The instruments segment is further divided into devices and equipment, while consumables include sensors and other items.
Method: The methods used in organoid development include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion, and others. The hanging drop method was the most prominent in 2023.

Market Outlook

Technological advancements are driving the integration of organoids with organ-on-a-chip technologies, enhancing applications in biological and biomedical research, particularly in disease modeling and clinical drug screening. Organoids combined with organ-on-a-chip technologies are transforming cancer research paradigms and offering tangible clinical benefits. The collaborative use of organoids with organ-on-a-chip and 3D bioprinting is paving the way for sophisticated cancer models that investigate tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment dynamics. The development of organoid-on-a-chip systems, which incorporate multiple organoids on a single chip, is an emerging area with significant potential for studying complex cancer interactions.

Country Insights

The South and Central America organoids market is primarily represented by Brazil, Argentina, and other regions, with Brazil holding the largest market share in 2023. Brazil is notable for its extensive kidney and liver transplant programs, ranking second globally. Despite regional disparities in organ donation and allocation, factors such as public acceptance of organ donation, equitable healthcare systems, supportive government policies, and the presence of dedicated healthcare professionals have contributed to the success of Brazil's transplantation initiatives. As of December 2022, approximately 53,000 organ transplants from deceased donors were performed in Brazil, marking a significant achievement in over two decades. The demand for organoids is further fueled by the need for transplants, as they can be developed from a patient’s healthy cells to aid in tissue repair post-transplantation. Ongoing research in Brazil is enhancing organoid development through 3D printing technologies, combining bioengineering techniques with pluripotent stem cell cultivation.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, LLC, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc., Corning Inc., Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne Corp, SUN bioscience SA, ORGANOID SCIENCES Co., Ltd., Crown Bioscience Inc., Sartorius AG, 3D Biotek LLC, Prellis Biologics Inc., 3Dnamics Inc., and Cellesce Ltd. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America organoids market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. Show more